Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v3.22.1
Equity (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Jun. 16, 2021
Dec. 29, 2020
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2016
Stockholders' Equity (Details) [Line Items]              
Proceeds from Warrant Exercises $ 138.1            
Outstanding warrants (in Shares)     3,914,525   3,914,525    
Options issued     688,240        
Number of shares, exercised     (50,000)        
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 11.50        
Weighted Average Exercise Price, Exercised (in Dollars per share)     $ 3.28        
Public Warrants              
Stockholders' Equity (Details) [Line Items]              
Warrants And Rights Exercised 12,033,169            
Warrants And Rights Redeemed 50,965            
Outstanding warrants (in Shares)           10,000,000  
Class of Warrant or Right, Exercise Price of Warrants or Rights           $ 11.50  
Legacy Danimer options              
Stockholders' Equity (Details) [Line Items]              
Options issued             208,183
Weighted Average Exercise Price of per share (in Dollars per share)   $ 30          
Number of shares, exercised         153,763    
Exercisable and remained outstanding ( in shares)   30,493          
Conversion of Stock, Shares Issued   279,255          
Number of options exercised remains     125,489        
Weighted Average Exercise Price, Exercised (in Dollars per share)   $ 3.28          
Legacy Danimer warrants              
Stockholders' Equity (Details) [Line Items]              
Outstanding warrants (in Shares)   55,319          
Weighted Average Exercise Price of per share (in Dollars per share)           $ 3.28  
Conversion of Stock, Shares Converted           506,611  
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 30          
Conversion of Stock, Shares Issued       435,961